FindTrial
Sign In

Study on the diagnostic efficacy of upright tilt test combined with TCD cerebral blood flow monitoring in improving syncope

Study on the diagnostic efficacy of upright tilt test combined with TCD cerebral blood flow monitoring in improving syncope

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073595
Enrollment
Unknown
Registered
2023-07-15
Start date
2023-07-10
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

syncope

Interventions

Gold Standard:The upright tilt test was positive.
Index test:upright tilt test combined with TCD cerebral blood flow monitoring

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients suspected of syncope. 2.Patients aged 18-80 who can cooperate with the upright tilt table test and dynamic TCD cerebral blood flow monitoring. 2.able to give informed consent.

Exclusion criteria

Exclusion criteria: 1.The patient's condition is unstable, 2.Severe intracranial and extracranial vascular stenosis, severe stenosis of coronary artery, aortic valve and mitral valve, and severe hypertrophic obstructive cardiomyopathy, 3.Severe anemia 4.severe arrhythmia 5.moderate and severe hypertension 6.pregnancy

Design outcomes

Primary

MeasureTime frame
average cerebral blood flow velocity;Lying and standing blood pressure;heart rate while lying and standing ;sensitivity;specificity;ROC curve;—

Countries

China

Contacts

Public ContactHu Huoyou

Shenzhen Second People's Hospital

huhuoyou1029@163.com+86 135 5491 8106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026